Trade FENC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Fennec Pharmaceuticals Inc. (FENC) is trading at US$10.96, down 3.01% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$395.91M. Over the past 52 weeks, FENC has traded between US$5.65 and US$13.25. On Syfe you can trade FENC with $0 commission and add it to your watchlist.
| Previous close | US$11.30 |
|---|---|
| Market cap | US$395.91M |
| P/E ratio | 14.71 |
| 52-week range | US$5.65 – US$13.25 |
| Volume | 249.93K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Year: 2002
--B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating
Aug 12, 11:56 AM · MT Newswires
--Wedbush Adjusts Fennec Pharmaceuticals PT to $16 From $13, Maintains Outperform Rating
Aug 11, 2:59 PM · MT Newswires
Fennec Pharmaceuticals Says University of Arizona Begins Cancer Study in Adolescents, Adults
Apr 7, 12:00 PM · MT Newswires
Fennec Pharmaceuticals Inc. (FENC) stock is trading at US$10.96, -3.01% from the previous close of US$11.30.
The market cap for Fennec Pharmaceuticals Inc. (FENC) stock is approximately US$395.91M.
The price-to-earnings ratio for Fennec Pharmaceuticals Inc. (FENC) is 14.71, based on the latest reported earnings.
The 52-week high for Fennec Pharmaceuticals Inc. (FENC) stock is US$13.25.
The 52-week low for Fennec Pharmaceuticals Inc. (FENC) stock is US$5.65.
Fennec Pharmaceuticals Inc. (FENC) does not currently pay a dividend.
Stay on top of FENC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
